Shawn Vincent, Founder & CEO
Shawn is a dynamic and highly motivated CEO and Founder, previously Senior Sales Executive with solid track record of outstanding performance in increasing sales and retaining customer patronage. Known throughout the market for delivering and sustaining revenues by collaborating with an established network for 20 years in pharmaceutical, genetic testing and healthcare, with a particular emphasis on “big data” analytics. Strong knowledge of territory management, national accounts and market share growth along with great experience in handling sales analysis and reporting duties. Demonstrated ability to ramp quickly by identifying opportunities to optimize sales growth and succeed in industry adjacencies. Consistent progression in roles that provided holistic perspective, which created a positive culture empowering sales leaders to excel and advance their personal development.
Lara Zimmerman, Advisor – Product Positioning, Founder Coaching
Lara collaborates closely with every client who comes on board, laying the strategic groundwork essential for sustainable growth. She brings a wealth of experience in early-stage startup coaching, product positioning, strategic development, and operations honed over a decade at the Harvard Innovation Labs, the Global Accelerator Network, and within various startups. She excels at helping clients effectively position their products in the market and build exceptional companies.
She holds a Bachelor’s in anthropology and a Master’s in management and is an exceptional connector, insightful advisor, and savvy market strategist.
Jill Chisholm, Clinical Advisor
Jill is the Founder and CEO of GeneScreen Genetic Counseling, founded in 2013. She obtained her B.S.N from Georgetown University, then received her M.S.N. from Columbia University and graduated as a Women’s Health Nurse Practitioner specializing in genetics. Jill worked as a Nurse in infertility and reproductive endocrinology for seven years before working as a nurse practitioner in obstetrics and gynecology for ten years. She also spent 1 year in genetic research at Rockefeller University in New York. Jill was a finalist for the Leading Women Entrepreneurs award in 2015 and was recognized as one of the Top 25 in 2016. In 2017, she received a nomination from Smart CEO. In 2024, Jill was honored as an Ernst & Young Entrepreneur of the Year.
Thomas Neyarapally, Business Advisor
Tom Neyarapally is currently the CEO & Co-Founder of Archetype Therapeutics, an AI-native company pioneering the use of generative chemogenomics in patient data-driven drug discovery. Previously he held the role of CCO on the founding team at Sema4, a patient-centered health intelligence and genetic testing company. He was also a member of the founding team and Executive Vice President, Corporate Development at the causal AI drug discovery company Aitia. Tom served as a corporate and IP lawyer at Chadbourne & Parke LLP and Frommer Lawrence & Haug LLP. He started his career as an analyst at the consulting firm Arthur D. Little. Tom received his degree in chemical engineering, cum laude and as an Honors Scholar, from the University of Connecticut, and JD and MBA degrees from Cornell University.
John Ramos, Business Advisor
John Ramos leads Phoenix Group Advisors, a one-stop solution for medical office needs, specializing in medical equipment repair, surgical device sales for OB-GYNs, office relocations, liquidations, and practice consulting. With 19 years of experience in the medical industry, John is a seasoned sales and marketing professional focused on laboratory services and women’s health.
Having served as a Field Sales Trainer and Director of Sales for major laboratory groups, John is known for his collaborative leadership style and consistent results. He has built a strong network in the medical community, earning respect for his integrity and dedication to client needs.
Fluent in English and Spanish, John enhances engagement across diverse markets, extending Blue Cardinal’s reach in the medical field.
Blue Cardinal Advisors 